Your browser doesn't support javascript.
loading
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death-1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105-204).
Zheng, Yulong; Zhu, Jianqing; Xiong, Jianping; Jiang, Ou; Wang, Hong; Xie, Yanru; Zhou, Yuefen; Xu, Nong.
Afiliación
  • Zheng Y; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zhu J; Department of Gynecologic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
  • Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Jiang O; Department of Tumor Surgery, Neijiang Second People's Hospital, Neijiang, Sichuan, China.
  • Wang H; Department of Oncology, The Third Hospital of Nanchang, Nanchang, Jiangxi, China.
  • Xie Y; Department of Oncology, Lishui City Central Hospital, Lishui, Zhejiang, China.
  • Zhou Y; Department of Oncology, Lishui City Central Hospital, Lishui, Zhejiang, China.
  • Xu N; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Cancer ; 130(12): 2180-2190, 2024 Jun 15.
Article en En | MEDLINE | ID: mdl-38412283

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2024 Tipo del documento: Article País de afiliación: China